Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo
作者:Zhenya Wang、Jieyu Fang、Jiao Luo、Duoduo Hou、Yayun Tan、Zichen Gu、Yongzhuang Ge、Lu Mao、Luyang Liu、Hongmin Liu、Zhanyong Wei、Haiwei Xu
DOI:10.3390/v13020278
日期:——
Influenza A virus is a highly variable and contagious respiratory pathogen that can cause annual epidemics and it poses an enormous threat to public health. Therefore, there is an urgent need for a new generation of antiviral drugs to combat the emergence of drug-resistant strains of the influenza virus. A novel series of butene lactone derivatives were screened and the compound 3D was selected, as
甲型流感病毒是一种高度可变且具有传染性的呼吸道病原体,可引起年度流行病,并对公众健康构成巨大威胁。因此,迫切需要新一代抗病毒药物来对抗流感病毒耐药株的出现。筛选了一系列新的丁烯内酯衍生物并选择了化合物 3D,因为它在体外表现出潜在的抗 A/Weiss/43 H1N1 病毒的低毒抗病毒活性。此外,3D 剂量依赖性地抑制病毒复制、病毒 mRNA 和病毒蛋白的表达。3D 在体外对 A/Virginia/ATCC2/2009 H1N1 和 A/California/2/2014 H3N2 产生抑制作用。添加时间分析表明 3D 在其生命周期的早期阶段抑制了 H1N1。A/Weiss/43 H1N1 诱导的 A549 细胞凋亡通过线粒体凋亡途径通过 3D 减少。3D 可以减少 H1N1 诱导的促炎细胞因子的产生,这些细胞因子在体外和体内由 H1N1 诱导。3D 的给药减少了体内肺部病变和病毒载量。这些结果表明,3D